List of works - Anthony L DeVico

An alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence

scientific article

An immunoglobulin fusion protein based on the gp120-CD4 receptor complex potently inhibits human immunodeficiency virus type 1 in vitro

scientific article published on June 2006

Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens

scholarly article

Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development

scientific article

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family

scientific article

Antigenic properties of the HIV envelope on virions in solution

scientific article

Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells

scientific article (publication date: March 2015)

Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion

scientific article

Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection

scientific article

CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1.

scientific article published on June 2007

CD4-induced epitopes in the HIV envelope glycoprotein, gp120.

scientific article

Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1

scientific article published on 17 June 2015

Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1

scientific article

Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission

scientific article

Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a "stochastic" process

scientific article

Control of HIV-1 infection by soluble factors of the immune response

scientific article published on May 2004

Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure

scientific article published on 17 January 2002

Correlation between circulating HIV-1 RNA and broad HIV-1 neutralizing antibody activity.

scientific article

Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques

scientific article

Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1.

scientific article

Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments

scientific article

Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection

scientific article

Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding

scientific article

Enhanced Immune Responses to HIV-1 Envelope Elicited by a Vaccine Regimen Consisting of Priming with Newcastle Disease Virus Expressing HIV gp160 and Boosting with gp120 and SOSIP gp140 Proteins

scientific article

Epitope target structures of Fc-mediated effector function during HIV-1 acquisition

scientific article

Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model

scientific article published on January 2007

HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques

scientific article

HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses

scientific article

Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection

scientific article published on 22 June 2016

Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro

scientific article

Identification and Characterization of an Immunogenic Hybrid Epitope Formed by both HIV gp120 and Human CD4 Proteins.

scientific article published in May 2012

Identification and characterization of an immunogenic hybrid epitope formed by both HIV gp120 and human CD4 proteins

scientific article published on 12 October 2011

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

scientific article (publication date: 5 April 2012)

Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunization

scientific article

Newcastle Disease Virus Expressing Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces Strong Mucosal and Serum Antibody Responses in Guinea Pigs ⬇️

scientific article published on August 17, 2011

Paring Down HIV Env: Design and Crystal Structure of a Stabilized Inner Domain of HIV-1 gp120 Displaying a Major ADCC Target of the A32 Region

scientific article

Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5.

scientific article

Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro

scientific article published on 7 May 2007

Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands

scientific article

Signature biochemical properties of broadly cross-reactive HIV-1 neutralizing antibodies in human plasma.

scientific article

Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases

scientific article

Structural Definition of an Antibody-Dependent Cellular Cytotoxicity Response Implicated in Reduced Risk for HIV-1 Infection

scientific article (publication date: November 2014)

Survivors Remorse: antibody-mediated protection against HIV-1.

scientific article

Synergistic Inhibition of R5 HIV-1 by the Fusion Protein (FLSC) IgG1 Fc and Maraviroc in Primary Cells: Implications for Prevention and Treatment

scientific article published on 9 September 2015

Synergistic inhibition of R5 HIV-1 by maraviroc and CCR5 antibody HGS004 in primary cells: implications for treatment and prevention ⬇️

scientific article published on June 1, 2011

Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates

scientific article published on 27 May 2015

λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein Antibodies

scientific article

List of works by Anthony L DeVico

An alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence

An immunoglobulin fusion protein based on the gp120-CD4 receptor complex potently inhibits human immunodeficiency virus type 1 in vitro

Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens

Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family

Antigenic properties of the HIV envelope on virions in solution

Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells

Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion

Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection

CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1.

CD4-induced epitopes in the HIV envelope glycoprotein, gp120.

Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1

Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1

Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission

Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a "stochastic" process

Control of HIV-1 infection by soluble factors of the immune response

Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure

Correlation between circulating HIV-1 RNA and broad HIV-1 neutralizing antibody activity.

Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques

Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1.

Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments

Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection

Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding

Enhanced Immune Responses to HIV-1 Envelope Elicited by a Vaccine Regimen Consisting of Priming with Newcastle Disease Virus Expressing HIV gp160 and Boosting with gp120 and SOSIP gp140 Proteins

Epitope target structures of Fc-mediated effector function during HIV-1 acquisition

Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model

HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques

HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses

Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection

Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro

Identification and Characterization of an Immunogenic Hybrid Epitope Formed by both HIV gp120 and Human CD4 Proteins.

Identification and characterization of an immunogenic hybrid epitope formed by both HIV gp120 and human CD4 proteins

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunization

Newcastle Disease Virus Expressing Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces Strong Mucosal and Serum Antibody Responses in Guinea Pigs ⬇️

Paring Down HIV Env: Design and Crystal Structure of a Stabilized Inner Domain of HIV-1 gp120 Displaying a Major ADCC Target of the A32 Region

Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5.

Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro

Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands

Signature biochemical properties of broadly cross-reactive HIV-1 neutralizing antibodies in human plasma.

Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases

Structural Definition of an Antibody-Dependent Cellular Cytotoxicity Response Implicated in Reduced Risk for HIV-1 Infection

Survivors Remorse: antibody-mediated protection against HIV-1.

Synergistic Inhibition of R5 HIV-1 by the Fusion Protein (FLSC) IgG1 Fc and Maraviroc in Primary Cells: Implications for Prevention and Treatment

Synergistic inhibition of R5 HIV-1 by maraviroc and CCR5 antibody HGS004 in primary cells: implications for treatment and prevention ⬇️

Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates

λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein Antibodies